Skip to main content
NASDAQ:VSPR

Vesper Healthcare Acquisition Competitors

$11.98
-0.37 (-3.00 %)
(As of 05/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$11.71
$12.39
50-Day Range
$9.91
$13.05
52-Week Range
$9.71
$13.29
Volume460,119 shs
Average Volume803,775 shs
Market Capitalization$688.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Vesper Healthcare Acquisition (NASDAQ:VSPR) Vs. AJAX, AJAX, PNTM, BOAC, BTWN, and BOWX

Should you be buying VSPR stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to Vesper Healthcare Acquisition, including Ajax I (AJAX), Ajax I (AJAX), Pontem (PNTM), Bluescape Opportunities Acquisition (BOAC), Bridgetown (BTWN), and BowX Acquisition (BOWX).

Ajax I (NYSE:AJAX) and Vesper Healthcare Acquisition (NASDAQ:VSPR) are both small-cap unclassified companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Earnings & Valuation

This table compares Ajax I and Vesper Healthcare Acquisition's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Ajax I and Vesper Healthcare Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Vesper Healthcare Acquisition00203.00

Vesper Healthcare Acquisition has a consensus target price of $15.75, indicating a potential upside of 31.47%. Given Vesper Healthcare Acquisition's higher possible upside, analysts plainly believe Vesper Healthcare Acquisition is more favorable than Ajax I.

Profitability

This table compares Ajax I and Vesper Healthcare Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/A

Summary

Vesper Healthcare Acquisition beats Ajax I on 2 of the 2 factors compared between the two stocks.

Ajax I (NYSE:AJAX) and Vesper Healthcare Acquisition (NASDAQ:VSPR) are both small-cap unclassified companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, risk, profitability and valuation.

Analyst Ratings

This is a breakdown of current recommendations and price targets for Ajax I and Vesper Healthcare Acquisition, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
Vesper Healthcare Acquisition00203.00

Vesper Healthcare Acquisition has a consensus target price of $15.75, indicating a potential upside of 31.47%. Given Vesper Healthcare Acquisition's higher possible upside, analysts clearly believe Vesper Healthcare Acquisition is more favorable than Ajax I.

Profitability

This table compares Ajax I and Vesper Healthcare Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/A

Valuation & Earnings

This table compares Ajax I and Vesper Healthcare Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/AN/AN/A

Summary

Vesper Healthcare Acquisition beats Ajax I on 2 of the 2 factors compared between the two stocks.

Vesper Healthcare Acquisition (NASDAQ:VSPR) and Pontem (NYSE:PNTM) are both small-cap financial services companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, earnings, dividends and profitability.

Valuation & Earnings

This table compares Vesper Healthcare Acquisition and Pontem's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vesper Healthcare AcquisitionN/AN/AN/AN/AN/A
PontemN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Vesper Healthcare Acquisition and Pontem, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vesper Healthcare Acquisition00203.00
Pontem0000N/A

Vesper Healthcare Acquisition presently has a consensus price target of $15.75, indicating a potential upside of 31.47%. Given Vesper Healthcare Acquisition's higher possible upside, equities research analysts plainly believe Vesper Healthcare Acquisition is more favorable than Pontem.

Profitability

This table compares Vesper Healthcare Acquisition and Pontem's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Vesper Healthcare AcquisitionN/AN/AN/A
PontemN/AN/AN/A

Summary

Vesper Healthcare Acquisition beats Pontem on 2 of the 2 factors compared between the two stocks.

Bluescape Opportunities Acquisition (NYSE:BOAC) and Vesper Healthcare Acquisition (NASDAQ:VSPR) are both small-cap unclassified companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation.

Earnings & Valuation

This table compares Bluescape Opportunities Acquisition and Vesper Healthcare Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/AN/AN/A

Profitability

This table compares Bluescape Opportunities Acquisition and Vesper Healthcare Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Bluescape Opportunities AcquisitionN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings for Bluescape Opportunities Acquisition and Vesper Healthcare Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bluescape Opportunities Acquisition0000N/A
Vesper Healthcare Acquisition00203.00

Vesper Healthcare Acquisition has a consensus target price of $15.75, indicating a potential upside of 31.47%. Given Vesper Healthcare Acquisition's higher possible upside, analysts clearly believe Vesper Healthcare Acquisition is more favorable than Bluescape Opportunities Acquisition.

Summary

Vesper Healthcare Acquisition beats Bluescape Opportunities Acquisition on 2 of the 2 factors compared between the two stocks.

Bridgetown (NASDAQ:BTWN) and Vesper Healthcare Acquisition (NASDAQ:VSPR) are both small-cap unclassified companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability and dividends.

Profitability

This table compares Bridgetown and Vesper Healthcare Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Bridgetown and Vesper Healthcare Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
Vesper Healthcare Acquisition00203.00

Vesper Healthcare Acquisition has a consensus target price of $15.75, indicating a potential upside of 31.47%. Given Vesper Healthcare Acquisition's higher possible upside, analysts clearly believe Vesper Healthcare Acquisition is more favorable than Bridgetown.

Valuation & Earnings

This table compares Bridgetown and Vesper Healthcare Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
Vesper Healthcare AcquisitionN/AN/AN/AN/AN/A

Summary

Vesper Healthcare Acquisition beats Bridgetown on 2 of the 2 factors compared between the two stocks.

Vesper Healthcare Acquisition (NASDAQ:VSPR) and BowX Acquisition (NASDAQ:BOWX) are both small-cap financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.

Profitability

This table compares Vesper Healthcare Acquisition and BowX Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Vesper Healthcare AcquisitionN/AN/AN/A
BowX AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Vesper Healthcare Acquisition and BowX Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vesper Healthcare Acquisition00203.00
BowX Acquisition0000N/A

Vesper Healthcare Acquisition currently has a consensus target price of $15.75, indicating a potential upside of 31.47%. Given Vesper Healthcare Acquisition's higher probable upside, research analysts plainly believe Vesper Healthcare Acquisition is more favorable than BowX Acquisition.

Valuation and Earnings

This table compares Vesper Healthcare Acquisition and BowX Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vesper Healthcare AcquisitionN/AN/AN/AN/AN/A
BowX AcquisitionN/AN/AN/AN/AN/A

Summary

Vesper Healthcare Acquisition beats BowX Acquisition on 2 of the 2 factors compared between the two stocks.


Vesper Healthcare Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$9.95-0.1%$889.96 millionN/A0.00
Ajax I logo
AJAX
Ajax I
0.0$9.95-0.1%$889.96 millionN/A0.00
PNTM
Pontem
0.0$9.75-0.3%$840.94 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$9.99-0.2%$758.62 millionN/A0.00
BTWN
Bridgetown
0.0$9.96-0.4%$740.77 millionN/A0.00
BOWX
BowX Acquisition
0.0$12.02-1.9%$725.71 millionN/A0.00
VYGG
Vy Global Growth
0.0$9.94-0.5%$714.44 millionN/A0.00
LGAC
Lazard Growth Acquisition Corp. I
0.0$9.74-0.1%$700.06 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.55-5.9%$679.16 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.02-0.2%$664.27 millionN/A0.00News Coverage
ASZ
Austerlitz Acquisition Co. II
0.0$9.81-0.0%$631.25 millionN/A0.00News Coverage
ACIC
Atlas Crest Investment
0.0$9.85-0.1%$615.63 millionN/A0.00
CMLF
CM Life Sciences
0.0$11.11-3.2%$614.87 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.71-0.0%$606.88 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$13.15-5.9%$575.31 millionN/A0.00
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.21-0.8%$574.31 millionN/A0.00
VAQC
Vector Acquisition Co. II
0.0$9.96-0.1%$571.21 millionN/A0.00News Coverage
GSEV
Gores Holdings VII
0.0$9.94-0.5%$560.42 millionN/A0.00
KVSC
Khosla Ventures Acquisition Co. III
0.0$9.95-0.1%$560.19 millionN/A0.00
HAAC
Health Assurance Acquisition
0.0$10.09-0.6%$558.73 millionN/A0.00News Coverage
MUDS
Mudrick Capital Acquisition Co. II
0.0$13.23-9.4%$523.00 millionN/A0.00
MAAC
Montes Archimedes Acquisition
0.0$9.89-0.1%$519.94 millionN/A0.00
NGAB
Northern Genesis Acquisition Corp. II
0.0$9.93-0.5%$513.88 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.82-0.4%$508.19 millionN/A0.00
MOTV
Motive Capital
0.0$9.79-0.2%$506.63 millionN/A0.00
DGNU
Dragoneer Growth Opportunities Corp. III
0.0$10.10-0.3%$505 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.75-0.1%$499.33 millionN/A0.00
EPHY
Epiphany Technology Acquisition
0.0$9.75-0.1%$498.34 millionN/A0.00
Supernova Partners Acquisition logo
SPNV
Supernova Partners Acquisition
0.0$9.86-0.4%$496.09 millionN/A0.00High Trading Volume
GMII
Gores Metropoulos II
0.0$9.91-0.2%$495.50 millionN/A0.00
NSTD
Northern Star Investment Corp. IV
0.0$9.86-0.8%$493 millionN/A0.00
DCRN
Decarbonization Plus Acquisition Co. II
0.0$9.76-0.4%$491.06 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.75-0.1%$490.55 millionN/A0.00
SRNG
Soaring Eagle Acquisition
0.0$9.89-0.2%$489.43 millionN/A0.00High Trading Volume
News Coverage
AGCB
Altimeter Growth Corp. 2
0.0$10.36-0.7%$466.20 millionN/A0.00
NGAC
NextGen Acquisition
0.0$9.88-0.0%$463.13 millionN/A0.00
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.01-0.3%$461.46 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.79-0.1%$445.38 millionN/A0.00
LUXA
Lux Health Tech Acquisition
0.0$10.05-0.3%$433.41 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.91-0.1%$427.37 millionN/A0.00
SPFR
Jaws Spitfire Acquisition
0.0$9.89-0.7%$426.51 millionN/A0.00
RMGB
RMG Acquisition Co. II
0.0$9.89-0.1%$426.51 millionN/A0.00
ACII
Atlas Crest Investment Corp. II
0.0$9.79-0.1%$422.19 millionN/A0.00
DHHC
DiamondHead
0.0$9.75-0.0%$420.47 millionN/A0.00
KURI
Alkuri Global Acquisition
0.0$9.73-0.1%$419.61 millionN/A0.00
GFX
Golden Falcon Acquisition
0.0$9.70-0.2%$418.31 millionN/A0.00
CBAH
CBRE Acquisition
0.0$9.83-0.1%$415.45 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.49-0.0%$411.58 millionN/A0.00News Coverage
NSTB
Northern Star Investment Corp. II
0.0$9.92-0.1%$396.80 millionN/A0.00
SWBK
Switchback II
0.0$9.85-1.2%$389.38 millionN/A0.00High Trading Volume
This page was last updated on 5/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.